Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-23
2000-01-04
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514521, 514466, 514931, A61K 3142, A61K 3136, A61K 31275
Patent
active
060110511
ABSTRACT:
Compounds of the formula I or II ##STR1## are suitable for the production of pharmaceuticals for the modulation of apoptosis. These compounds can be employed for the treatment of infarct, stroke, neurodegeneration or hypertrophic disorders.
REFERENCES:
patent: 4061767 (1977-12-01), Ertel et al.
patent: 4965276 (1990-10-01), Bartlett et al.
patent: 5240960 (1993-08-01), Hambleton et al.
patent: 5268382 (1993-12-01), Bartlett et al.
patent: 5308865 (1994-05-01), Bartlett et al.
patent: 5416112 (1995-05-01), Kuo
patent: 5459163 (1995-10-01), Bartlett et al.
patent: 5494911 (1996-02-01), Bartlett et al.
patent: 5504084 (1996-04-01), Bartlett et al.
patent: 5519042 (1996-05-01), Morris et al.
patent: 5547970 (1996-08-01), Weithmann et al.
patent: 5547971 (1996-08-01), Weithmann et al.
patent: 5554637 (1996-09-01), Weithmann et al.
patent: 5556870 (1996-09-01), Weithmann et al.
patent: 5624946 (1997-04-01), Williams
patent: 5856330 (1999-01-01), Mullner et al.
Samstag, Y. et al, J. of Immunology, "Inhibition of Constitutive Serine Phosphatase Activity in T Lymphoma Cells Results in Phosphorylation of pp19/Cofilin and Induces Apoptosis", pp. 4167-4173 (1996).
Dax Claudia
Mullner Stefan
Criares Theodore J.
Hoechst Aktiengesellschaft
LandOfFree
Use of isoxazole and crotonamide derivatives for the modulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of isoxazole and crotonamide derivatives for the modulation , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of isoxazole and crotonamide derivatives for the modulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072946